Overview

Wellnara Post-marketing Surveillance in Japan

Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
0
Participant gender:
Female
Summary
This study is a regulatory post marketing surveillance in Japan, and it is a local prospective and observational study of patients who have received Wellnara for postmenopausal osteoporosis. The objective of this study is to assess safety and efficacy of using Wellnara in clinical practice. A total 400 patients will be recruited and followed 3 years since starting Wellnara administration.
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Bayer
Criteria
Inclusion Criteria:

- Patients who received Wellnara for postmenopausal osteoporosis

Exclusion Criteria:

- Patients who are contraindicated based on the product label